Lutte contre Pseudomonas aeruginosa responsable des infections nosocomiales

dc.contributor.authorACHACHE, Hadjer
dc.contributor.authorBOUKOUCHA, Nadjet
dc.date.accessioned2025-10-14T11:11:34Z
dc.date.available2025-10-14T11:11:34Z
dc.date.issued2025-07-02
dc.description.abstractNosocomial infections represent a major public health issue, particularly due to the increasing antibiotic resistance of Pseudomonas aeruginosa. This study focused on evaluating the antimicrobial activity of several natural extracts, including plant extracts (Lawsonia inermis, Allium sativum), 13 fungal isolates (one identified as Aspergillus sp.), and honey, against two P. aeruginosa strains : a reference strain (ATCC 27853) and a clinical isolate (I1). The results revealed that only the extracts of A. sativum, L. inermis, and Aspergillus sp. exhibited significant antimicrobial activity. For Aspergillus sp., inhibition zones measured 20,6 mm (ATCC strain) and 20 mm (I1 Isolate), with a MIC of 25 mg/mL and an MBC of 50 mg/ml. A. sativum showed inhibition zones of 22,1 mm (ATCC strain) and 9,8 mm (I1 Isolate), with MIC and MBC values of 25% and 50%, respectively. L. inermis showed inhibition zones of 13,3 mm (ATCC strain) and 12,4 mm (I1 Isolate), with both MIC and MBC values of 7,5 mg/ml. A CMB/MIC ratio of 1 was observed for A. sativum and L. inermis, indicating marked bactericidal activity. Moreover, co-culture with Aspergillus sp. led to an increase in pyocyanin production in the ATCC strain (from 1,758 to 2,527 μg/ml), while a slight decrease was observed in the I1 isolate (from 0,734 to 0,666 μg/ml). These results suggest a strong potential for these natural extracts as therapeutic alternatives against multidrug-resistant P. aeruginosa strains and justify further research for in vivo and clinical applications.en_US
dc.identifier.urihttp://e-biblio.univ-mosta.dz/handle/123456789/29597
dc.language.isofren_US
dc.subjectPseudomonas aeruginosa, nosocomial infections, antibiotic resistance, Allium sativum, Lawsonia inermis, Aspergillus sp., antibacterial activity, pyocyaninen_US
dc.titleLutte contre Pseudomonas aeruginosa responsable des infections nosocomialesen_US
dc.typeOtheren_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mémoire Finale H & N & A 02-07-2025.pdf
Size:
12.65 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: